Mr. Bill Ciprick reports

OPTIMI HEALTH GRANTED NATURAL HEALTH PRODUCT SITE LICENCE BY HEALTH CANADA

Optimi Health Corp. has received its natural health product site licence following an assessment by the Natural and Non-prescription Health Products Directorate.

Under Section 29 of the Natural Health Products Regulations, the expanded licensing allows for the manufacturing, packaging and labelling of natural health products (NHPs) at the company's Princeton, B.C., facility.

Further, the licence also gives Optimi the ability to encapsulate products on site.

"This expands our ability to produce our products on site for global market distribution," said Bill Ciprick, Optimi chief executive officer. "This licence enables the company to further diversify, and leverage the potential of its existing manufacturing, processing and packaging capabilities to streamline fulfilment and reduce costs across its supply chain to support continued growth."

Today's announcement affirms Optimi's commitment to supplying large-scale research and development programs through its 10,000-square-foot GMP (good manufacturing practices)-compliant manufacturing facility.

About Optimi Health Corp.

Optimi Health is an end-to-end drug researcher and formulator licensed by Health Canada to produce and supply, for clinical research purposes, psychedelic substances such as 3,4-methylenedioxymethamphetamine (MDMA), natural GMP-grade psilocybin, as well as functional mushrooms that focus on the health and wellness markets. Built with the purpose of producing scalable psychedelic formulations for transformational human experiences, the company's goal is to be the No. 1 trusted, compassionate supplier of safe drug products throughout the world. Optimi's products are grown and manufactured at its two facilities comprising a total of 20,000 square feet in Princeton, B.C.

We seek Safe Harbor.